Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 in renal transplant recipients (extension study)
NCT00239798Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fingolimod in kidney transplant, sponsored by Novartis. Started Nov 2004; status: completed.
02
Drugs
fingolimod
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT00239798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239798.